EdgeLab S.p.A. Logo

EdgeLab S.p.A.

Specializing in underwater robotics, AUVs, and sensor systems for marine research and heritage.

ELB | Euronext Growth

Overview

Corporate Details

ISIN(s):
IT0005627762
LEI:
815600DEC35C84FE7546
Country:
Italy
Address:
Via della Ferriera 1, 57037 Portoferraio
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

EdgeLab S.p.A. is a high-technology company specializing in the development of marine and underwater solutions and technologies. Established in 2010 as a spinoff from scientific research projects, the company's core activities include underwater robotics, Autonomous Underwater Vehicles (AUVs), marine technologies, and advanced sensor systems. EdgeLab also provides research and consultancy services, with a focus on projects related to environmental sustainability and the preservation of underwater marine heritage. The company transitioned to a joint-stock company and was listed on Euronext Growth Milan in December 2024.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 18:42
Related Party Transaction
EDGELAB E KSSL SIGLANO UN ACCORDO STRATEGICO PER RAFFORZARE LA COOPERAZIONE IN…
Italian 267.9 KB
2025-10-13 20:01
Report Publication Announcement
EDGELAB PARTECIPA ALLA SESTA EDIZIONE DELLA CONFERENCE EQUITY “NEXT GEMS”
Italian 271.6 KB
2025-09-30 20:53
Earnings Release
EDGELAB: IL CONSIGLIO DI AMMINISTRAZIONE HA APPROVATO LA RELAZIONE SEMESTRALE …
Italian 522.5 KB
2025-08-07 12:36
Regulatory Filings
ACCORDO COMMERCIALE GOLDEN POWER BFL
Italian 269.2 KB
2025-04-30 16:00
AGM Information
L’ASSEMBLEA DEGLI AZIONISTI DI EDGELAB APPROVA IL BILANCIO 2024
Italian 282.4 KB
2025-04-10 12:57
Pre-Annual General Meeting Information
PUBBLICAZIONE DELL'AVVISO DI CONVOCAZIONE DELL'ASSEMBLEA ORDINARIA
Italian 302.6 KB
2025-02-21 15:08
Environmental & Social Information
Training_Soprintendenza del Mare-Regione Sicilia
Italian 256.7 KB
2025-01-28 17:44
Board/Management Information
IL CONSIGLIO DI AMMINISTRAZIONE DI EDGELAB S.P.A. HA APPROVATO I CRITERI VALUT…
Italian 269.4 KB
2025-01-15 18:48
Report Publication Announcement
CALENDARIO EVENTI SOCIETARI 2025
Italian 267.8 KB
2024-12-30 19:39
Regulatory Filings
EDGELAB DEBUTTA CON SUCCESSO SU EGM
Italian 275.5 KB

Automate Your Workflow. Get a real-time feed of all EdgeLab S.p.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EdgeLab S.p.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EdgeLab S.p.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ceres Power Holdings PLC Logo
Licensing solid oxide tech (SOFC/SOEC) for clean power and green hydrogen to global partners.
United Kingdom
CWR
Certara, Inc. Logo
Accelerating new medicines with biosimulation software and services for pharma & biotech.
United States of America
CERT
CervoMed Inc. Logo
Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.
United States of America
CRVO
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea
085660
CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America
CRL
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan
4583
Chordate Medical Holding AB Logo
Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.
Sweden
CMH
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan
190A
Cibus, Inc. Logo
Develops & licenses gene-edited, non-transgenic traits to the seed industry for resilient crops.
United States of America
CBUS

Talk to a Data Expert

Have a question? We'll get back to you promptly.